Ardelyx, Inc , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.
infoArdelyx is a small cap stock with a total market cap of 815.50M.
infoThey trade on the NASDAQ and had their IPO 9 years and 2 months ago.
infoArdelyx currently employs 133 people.
infoAs of Wednesday, Aug 23 2023, Ardelyx’s share price is $3.67.
News Relating to Ardelyx
PennyStocks
Best Penny Stocks To Buy Now? 4 Under $5 To Watch
Thursday Aug 10 2023 at 10:51
If you’re trying to find the best penny stocks to buy now, you’re not alone. There are plenty of reasons that support trading in these cheap stocks.
InvestorPlace
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
Monday Aug 07 2023 at 14:34
One of the safest sectors on the market is biotech. After all, we can’t stop people from aging — at least not yet.
PennyStocks
Penny Stocks To Buy Now? 3 With Ratings Up To 1,742%
Thursday Aug 03 2023 at 10:48
In a stock market characterized by growing unpredictability, traders are leaning on every possible resource. One such indispensable tool, whether dealing with penny stocks or more expensive shares, is the insight provided by analysts.
PennyStocks
Best Penny Stocks To Watch After Fitch Downgrade? 3 For Your List
Wednesday Aug 02 2023 at 12:15
Penny stocks are an interesting asset class. On any given day, you will see at least a handful experiencing extreme levels and explosive moves.
Seeking Alpha
August MDA Breakout Stocks Week 31 – 2023: High-Frequency Gainers To Give You An Edge
Monday Jul 31 2023 at 14:43
Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains in CLLS +16.8% AUTL+15.5% but the portfolio failed to hold gains. The streak of weekly picks gaining over 10% in less than a week has increased to 255 out of 322 trading weeks (79.2%) not including multiple gainers or warning signals.
PennyStocks
Best Penny Stocks To Buy? 6 To Watch Before Next Week
Friday Jul 28 2023 at 11:59
Penny stocks hold a distinctive charm for many investors. Amidst fluctuating market trends and the occasional downturn, there’s often a group of these low-cost stocks surging in value.
GlobeNewsWire
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
Thursday Jul 20 2023 at 16:05
WALTHAM, Mass., July 20, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will present on behalf of the company at the virtual H.C. Wainwright 2nd Annual Kidney Conference on Tuesday, July 25, 2023 at 2:00 P.M. Eastern Time.
PennyStocks
Best Penny Stocks To Buy? 3 To Watch Before Next Week
Friday Jun 09 2023 at 12:12
When it comes to day trading, penny stocks have carved out a niche of their own. Defined as shares trading for less than $5, these stocks belong to companies that often fly under the radar.
PennyStocks
3 Penny Stocks To Watch Before Next Week; Time To Buy?
Monday Jun 05 2023 at 16:35
Penny stocks often represent an intriguing opportunity for investors. Defined by the U.S. Securities and Exchange Commission as shares trading for less than $5, these stocks generally belong to small companies that may not yet have made their mark in the mainstream market.
GlobeNewsWire
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
Wednesday May 31 2023 at 08:00
WALTHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 8:30 a.m. ET in New York City.
Seeking Alpha
Ardelyx, Inc. (ARDX) Q1 2023 Earnings Call Transcript
Wednesday May 03 2023 at 22:51
Ardelyx, Inc. (NASDAQ:ARDX ) Q1 2023 Results Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Caitlin Lowie – Vice President, Corporate Communications and Investor Relations Mike Raab – President and Chief Executive Officer Susan Rodriguez – Chief Commercial Officer Justin Renz – Chief Financial and Operations Officer Conference Call Participants Yigal Nochomovitz – Citi Research Laura Chico – Wedbush Securities Joseph Thome – TD Cowen Christopher Raymond – Piper Sandler & Co. Matthew Kaplan – Ladenburg Thalmann Operator Good day. And welcome to the Ardelyx First Quarter 2023 Conference Call.
Zacks Investment Research
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
Wednesday May 03 2023 at 19:02
Ardelyx (ARDX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.21 per share a year ago.
GlobeNewsWire
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023
Wednesday Apr 26 2023 at 08:00
WALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Wednesday, May 3, 2023, at 4:30 p.m.
Seeking Alpha
Ardelyx: Underappreciated Biotech With Potential FDA Approval On Deck
Monday Apr 24 2023 at 03:34
Ardelyx: Underappreciated Biotech With Potential FDA Approval On Deck.
PennyStocks
Top Penny Stocks To Buy Now? 10 To Watch Under $5
Thursday Apr 13 2023 at 11:27
10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace
3 Penny Stocks to Add to Your Watchlist for Potential Breakouts
Tuesday Apr 11 2023 at 08:29
As an investor, it is essential to have a diverse range of stocks within a portfolio. Penny stocks may not make up most of someone’s holdings, but they are a crucial investment addition.
InvestorPlace
Tech Stocks Are Surging
Friday Mar 31 2023 at 21:02
The Nasdaq 100 is on a tear
PennyStocks
7 Top Penny Stocks Under $5; Time To Buy Now?
Wednesday Mar 29 2023 at 11:28
Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?
PennyStocks
4 Top Penny Stocks To Watch With Big Biotech News This Quarter
Wednesday Mar 08 2023 at 10:44
4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big Biotech News This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Seeking Alpha
Ardelyx Regulatory Catalyst Looms In April, But Invest In It Longer
Monday Mar 06 2023 at 08:00
Ardelyx’s sole marketed drug can’t keep the company afloat by itself until it gets broader insurance coverage. The company is resubmitting a new drug application as early as next month.
PennyStocks
3 Penny Stocks Insiders Are Active In, Time To Buy Or Sell Now?
Friday Mar 03 2023 at 11:03
Penny stocks insiders are selling? What the details suggest.
Seeking Alpha
Ardelyx, Inc. (ARDX) Q4 2022 Earnings Call Transcript
Thursday Mar 02 2023 at 22:22
Ardelyx, Inc. (NASDAQ:ARDX ) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Caitlin Lowie – VP, Corporate Communications and IR Mike Raab – President and CEO Justin Renz – CFO Susan Rodriguez – CCO Rob Blanks – Chief Regulatory Affairs and Quality Assurance Officer Conference Call Participants Laura Chico – Wedbush Securities Yigal Nochomovitz – Citi Peyton Bohnsack – TD Cowen Operator Good afternoon everyone and welcome to the Ardelyx Fourth Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.
Zacks Investment Research
Ardelyx (ARDX) Surpasses Q4 Earnings and Revenue Estimates
Thursday Mar 02 2023 at 18:49
Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
Monday Feb 20 2023 at 11:18
Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.
Zacks Investment Research
Ardelyx Inc. (ARDX) to Report Q4 Earnings: What’s in Store?
Wednesday Feb 15 2023 at 10:32
Ardelyx (ARDX) is expected to report better-than-expected sales growth of its only marketed product, Ibsrela (tenapanor) and provide an update on the NDA resubmission timeline for Xphozah, tenapanor.
PennyStocks
A Short Guide to Making Money With Penny Stocks in 2023
Saturday Feb 04 2023 at 11:00
Use these tips for making money with penny stocks The post A Short Guide to Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Zacks Investment Research
Is Ardelyx (ARDX) Stock Outpacing Its Medical Peers This Year?
Friday Feb 03 2023 at 11:17
Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.
PennyStocks
4 Penny Stocks To Buy According To Analysts & Targets Over 600%
Wednesday Jan 25 2023 at 09:33
Analysts have put these on their list of penny stocks to buy. Do you agree?
Zacks Investment Research
Is Ardelyx (ARDX) Outperforming Other Medical Stocks This Year?
Wednesday Jan 18 2023 at 11:19
Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.
PennyStocks
Penny Stocks To Buy In 2023? 3 To Watch In January
Friday Jan 06 2023 at 11:01
3 penny stocks to watch this week. The post Penny Stocks To Buy In 2023?
Ardelyx Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Ardelyx’s Altman Z-score is 0.25 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.
Derived from SEC.GOV filing dataopen_in_new
Ardelyx Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 8 insiders have sold $112.58K of common stock in Ardelyx on the stock market with no insider buying.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Ardelyx’s Income Quality of 0.98 is greater than its Industry Group of 0.69 (42.0% greater)
Ardelyx’s Income Quality of 0.98 is greater than its Major Industry Group of 0.71 (38.0% greater)
Ardelyx’s Income Quality of 0.98 is greater than its Sector of 0.75 (30.7% greater)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Ardelyx’s Current Ratio of 2.63 is lower than its Industry Group of 4.76 (-44.7% lower)
Ardelyx’s Current Ratio of 2.63 is lower than its Major Industry Group of 4.32 (-39.1% lower)
Ardelyx’s Current Ratio of 2.63 is in line with its Sector of 2.6 (1.2% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-14.28 & -1.27)
Cannot compare a negative PE Ratio (-14.28 & -1.1)
Cannot compare a negative PE Ratio (-14.28 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Ardelyx’s PB Ratio of 6.62 is greater than its Industry Group of 1.34 (394.0% greater)
Ardelyx’s PB Ratio of 6.62 is greater than its Major Industry Group of 1.4 (372.9% greater)
Ardelyx’s PB Ratio of 6.62 is greater than its Sector of 1.62 (308.6% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Ardelyx’s ROE of -0.46 is in line with its Industry Group of -0.44 (-4.5% lower)
Ardelyx’s ROE of -0.46 is lower than its Major Industry Group of -0.38 (-21.1% lower)
Ardelyx’s ROE of -0.46 is lower than its Sector of -0.03 (-1433.3% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Ardelyx’s ROCE of -0.35 is greater than its Industry Group of -0.42 (16.7% greater)
Ardelyx’s ROCE of -0.35 is in line with its Major Industry Group of -0.37 (5.4% greater)
Ardelyx’s ROCE of -0.35 is lower than its Sector of -0.04 (-775.0% lower)
Derived from SEC.GOV filing dataopen_in_new